Skip to main content
MOHMolina Healthcare IncSell4.0·$200.21-0.82%
Open full analysis

Molina Healthcare Inc (MOH) Stock Analysis

Breakout setup

SellHigh Confidence

Healthcare · Healthcare Plans

Sell if holding. Engine safety override at $200.21: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 4.0/10. Specifically: Elevated put/call ratio: 1.31; Below-average business quality.

Molina Healthcare provides managed care under Medicaid (75% of 2025 premium revenue, 4.57M members), Medicare, and Marketplace segments across 21 US states, serving approximately 5.5 million members total. Premium revenue was $43.1B in 2025 with an MCR of 91.7%; top four... Read more

$200.21+0.3% A.UpsideScore 4.0/10#11 of 11 Healthcare Plans
QualityF-score4 / 9FCF yield7.20%
Stop $186.20Target $200.85(resistance)A.R:R -1.1:1
Analyst target$190.25-5.0%16 analysts
$200.85our TP
$200.21price
$190.25mean
$129
$262

Sell if holding. Engine safety override at $200.21: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 4.0/10. Specifically: Elevated put/call ratio: 1.31; Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 67, MACD bullish. Score 4.0/10, high confidence.

Passes 6/7 gates (positive momentum, clean insider activity, no SEC red flags, earnings proximity 36d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: moderate.

10-K grounded · weekly refresh

About Molina Healthcare Inc

About Molina Healthcare Inc

Molina Healthcare generated $45.4 billion in total revenue in 2025, including $43.1 billion in premium revenue across approximately 5.5 million members in 21 states. Medicaid contributed $32.2 billion, or 75% of premium revenue; Medicare added $6.2 billion (14%); and Marketplace generated $4.5 billion (10%). The company's medical care ratio rose to 91.7% in 2025 from 89.1% in 2024, compressing net income from $1.179 billion to $472 million.

Molina earns revenue from per-member-per-month capitation payments under Medicaid, Medicare Advantage, Medicare Special Needs Plans, and Marketplace contracts with state agencies and CMS. Premium rates are fixed by government contract and typically revised annually, creating a lag when medical cost trends outpace rate adjustments — a dynamic that materially impacted the company in 2024 and 2025. The top four Medicaid state contracts — California ($4.2 billion, 13% of Medicaid premium), Texas ($5.7 billion, 18%), Washington ($4.2 billion, 13%), and New York ($3.2 billion, 10%) — together generated $17.3 billion, roughly 54% of total Medicaid premium revenue in 2025. Molina's Marketplace segment membership is tied to federal premium subsidies; advanced premium tax credits expired at year-end 2025, creating membership attrition risk in 2026 and an adverse selection shift in the overall Marketplace risk pool. The company has achieved a 90% Medicaid RFP re-procurement win rate since 2019, representing $14 billion in retained revenue.

Show full overview

The One Big Beautiful Bill Act is expected to drive a 15% to 20% reduction on 1.2 million members in Molina's Medicaid Expansion enrollment over the next two to three years, per the company's 2025 10-K — a contraction that could further raise per-member medical costs as healthier enrollees exit. Combined with the lapse of Marketplace premium subsidies, the company entered 2026 navigating simultaneous enrollment compression and acuity deterioration across two of its three largest revenue segments. Molina's long-term premium revenue growth target remains at 11% to 13%, and management indicated the company is on pace to surpass $50 billion in premium revenue in 2027.

See also: Healthcare · Healthcare Plans

From Molina Healthcare Inc's most recent 10-K filing, extracted June 11, 2026.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-06-17
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 22, 202636d to earnings· next earnings call

Thesis

Rewards
No bull case signals
Risks
Concentration risk — Product: Medicaid program (75.0%)
Target reached (-14.5% upside)
Quality below floor (3.0 < 4.0)

Key Metrics

P/E (TTM)54.1
P/E (Fwd)21.8
Mkt Cap$10.5B
EV/EBITDA8.2
Profit Mgn0.4%
ROE4.5%
Rev Growth-4.3%
Beta0.80
DividendNone
Rating analysts24

Quality Signals

Piotroski F4/9

Options Flow

P/C1.31bearish
IV61%elevated
Max Pain$85-57.5% vs spot

Concentration Risks(10-K Item 1A)

  • HIGHProductMedicaid program75%
    10-K Item 1: 'Our Medicaid premium revenue constituted 75% of our consolidated premium revenue in the year ended December 31, 2025.'
  • MEDIUMGeographictop four Medicaid states (CA, NY, TX, WA)54%
    10-K Item 1A: 'top four health plans were in California, New York, Texas, and Washington, with aggregate Medicaid premium revenue of $17.3 billion, or approximately 54% of total Medicaid premium revenue'
  • LOWGeographicTexas Medicaid18%
    10-K Item 1: 'Our Texas Medicaid contracts represented approximately $5,735 million, or 18%, of consolidated Medicaid premium revenue in 2025.'
  • LOWGeographicCalifornia Medicaid13%
    10-K Item 1: 'Our California Medicaid contracts represented premium revenue of approximately $4,170 million, or 13%, of our consolidated Medicaid premium revenue in 2025.'

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

5 floor-breakers

Revenue shrinking — -4.3% YoY. Growth thesis broken unless recovery story develops.static

Earnings Growth
0.0
Revenue Growth
1.4
Declining revenue: -4%

Technicals below the gate floor. Component breakdown shows what dragged the score down.static

Support Resistance
1.5
Bollinger
1.9
52w Position
2.2

Quality below the gate floor. Component breakdown shows what dragged the score down.static

Gross Margin
0.0
Net Margin
0.2
Operating Margin
0.7
Roa
1.3
Roe
1.5
Moat
3.1
Piotroski F
4.4
Current Ratio
5.9
Fcf Quality
10.0
Excellent cash conversion: 403% FCF/NINo competitive moat

No near-term catalyst priced in. Thesis progression will come from fundamentals grinding, not event reaction.static

Earnings History
0.0
Surprise Avg
0.0
Erm
5.0
Earnings Timing
5.0
News Activity
5.0
Earnings concerns: 1B/3M

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
0.0
Quality Rank
3.2
Value Rank
4.7
GatesA.R:R -1.1=NEGATIVEMomentum 7.1>=5.5Insider activity: OKNo SEC red flagsEARNINGS PROXIMITY 36d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARBreakoutSuitability: Moderate
RSI
67 · Neutral
20D MA 50D MA 200D MAGOLDEN CROSSSupport $172.71Resistance $204.95

Price Targets

$186
$201
A.Upside+0.3%
A.R:R-1.1:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! Target reached (-14.5% upside)
! Quality below floor (3.0 < 4.0)
! Negative risk/reward — downside exceeds upside

Earnings

B
M
M
M
1/4 beats
Next Earnings2026-07-22 (36d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MOH stock a buy right now?

Sell if holding. Engine safety override at $200.21: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 4.0/10. Specifically: Elevated put/call ratio: 1.31; Below-average business quality. Chart setup: Golden cross, above all MAs, RSI 67, MACD bullish. Prior stop was $186.20. Score 4.0/10, high confidence.

What is the MOH stock price target?

Take-profit target: $200.85 (+0.3% upside). Prior stop was $186.20. Stop-loss: $186.20.

What are the risks of investing in MOH?

Concentration risk — Product: Medicaid program (75.0%); Target reached (-14.5% upside); Quality below floor (3.0 < 4.0).

Is MOH overvalued or undervalued?

Molina Healthcare Inc trades at a P/E of 54.1 (forward 21.8). TrendMatrix value score: 5.3/10. Verdict: Sell.

What do analysts say about MOH?

24 analysts cover MOH with a consensus score of 3.4/5. Average price target: $190.

What does Molina Healthcare Inc do?Molina Healthcare provides managed care under Medicaid (75% of 2025 premium revenue, 4.57M members), Medicare, and...

Molina Healthcare provides managed care under Medicaid (75% of 2025 premium revenue, 4.57M members), Medicare, and Marketplace segments across 21 US states, serving approximately 5.5 million members total. Premium revenue was $43.1B in 2025 with an MCR of 91.7%; top four Medicaid states (California, New York, Texas, Washington) account for ~54% of Medicaid premium revenue.

Related stocks: ALHC (Alignment Healthcare, Inc.) · OSCR (Oscar Health, Inc.) · CI (The Cigna Group) · PGNY (Progyny, Inc.) · CLOV (Clover Health Investments, Corp)
Home Stocks MOH

Latest news

Latest News

Benzinga7d ago
Benzinga7d agoProduct
Benzinga13d agoAnalyst
Benzinga26d agoAnalyst
Benzinga34d ago
Benzinga37d agoAnalyst
Benzinga37d agoAnalyst
Benzinga37d agoAnalyst
Benzinga40d ago
Benzinga40d ago
Benzinga47d ago
Benzinga50d ago
Benzinga51d agoAnalyst
Benzinga51d agoAnalyst
Benzinga54d agoAnalyst
Benzinga55d ago
Benzinga55d ago
Benzinga55d agoEarnings
Benzinga56d agoEarnings
Benzinga56d agoEarnings
Loading more...